Current understanding of dysbiosis in disease in human and animal models

Inflammatory Bowel Diseases

Volumn 22, Issue 5, 2016, Pages 1137-1150

  Degruttola, Arianna K ^a   Low, Daren ^a   Mizoguchi, Atsushi ^b   Mizoguchi, Emiko ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

colorectal cancer; dysbiosis; fecal microbiota; IBD susceptibility genes; inflammatory bowel disease

Indexed keywords

ANTIBIOTIC AGENT; ATG16L1 PROTEIN; BUTYRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PROBIOTIC AGENT; PROTEIN; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; VITAMIN D; VOLATILE FATTY ACID;

ADHERENT INVASIVE ESCHERICHIA COLI; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTISM; BACTEROIDES; BIFIDOBACTERIUM ADOLESCENTIS; CANCER RISK; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COLORECTAL CANCER; COLORECTAL POLYP; COMMENSAL; COMORBIDITY; CROHN DISEASE; CYTOKINE PRODUCTION; DIALISTER INVISUS; DIET; DISEASE SEVERITY; DYSBIOSIS; EFFECTOR CELL; ENDOTOXEMIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FIRMICUTES; FRAMESHIFT MUTATION; FUSOBACTERIUM NUCLEATUM; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE INTOLERANCE; GRANULOMA; HUMAN; HYGIENE HYPOTHESIS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; LYMPH NODE METASTASIS; MACROPHAGE; MICROBIAL DIVERSITY; MICROBIOME; MISSENSE MUTATION; MONOCYTE; MYCOBACTERIUM AVIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARATUBERCULOSIS; PATHOGENESIS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RUMINOCOCCUS; RUMINOCOCCUS GNAVUS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; WESTERN DIET; ANIMAL; BIOLOGICAL MODEL; INFLAMMATORY BOWEL DISEASE; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DYSBIOSIS; HUMANS; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL;

EID: 84964841928     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000750     Document Type: Article

References (105)

1. Bien J, Palagani V, Bozko P, et al. The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease'. Ther Adv Gastroenterol. 2013; 6: 53-68
2. Knights D, Lassen K, Xavier R. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut. 2013; 62: 1505-1510
3. Li J, Butcher J, Mack D, et al. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2015; 21: 139-153
4. Shanahan F. The colonic microbiota in health and disease. Gastroenterology. 2013; 29: 49-54
5. Clayton E, Rea M, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009; 104: 1162-1169
6. Mondot S, Kang S, Furet JP, et al. Highlighting new phylogenetic specificities of Crohn's Disease microbiota. Inflamm Bowel Dis. 2011; 17: 185-192
7. Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Gastroenterology. 2009; 25: 301-305
8. Hedin C, McCarthy N, Louis P, et al. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Gut. 2014; 63: 1578-1586
9. Nguyen GC. Bugs, drugs: insights into the pathogenesis of inflammatory bowel disease. Am J Gastroenterol. 2011; 106: 2143-2145
10. Sokol H, Lay C, Seksik P, et al. Analysis of bacterial bowel communities of IBD patients: what has it revealed'. Inflamm Bowel Dis. 2008; 14: 858-867
11. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011; 60: 631-637
12. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: Friend of foe'. World J Gastroenterol. 2011; 17: 557-566
13. Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J. 2013; 7: 1256-1261
14. Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-Acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013; 62: 531-539
15. Moran C, Sheehan D, Shanahan F. The small bowel microbiota. Gastroenterology. 2015; 31: 130-136
16. Ogilvie LA, Jones BV. Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease'. Gut. 2012; 61: 1642-1643
17. Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol. 2014; 20: 16452-16463
18. Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014; 63: 1513-1521
19. Turnbaugh P, Ley R, Mahowald M, et al. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027-1031
20. Ley R, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102: 11070-11075
21. Hildebrandt M, Hoffmann C, Sherrill-Mix S, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009; 137: 1716-1724
22. Ley R, Turnbaugh P, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023
23. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101: 15718-15723
24. Turnbaugh P, Backhed F, Fulton L, et al. Diet-Induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3: 213-223
25. Backhed F, Manchester J, Semenkovich C, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007; 104: 979-984
26. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143: 913-916
27. Cani P, Amar J, Iglesias M, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56: 1761-1772
28. Giongo A, Gano K, Crabb D, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5: 82-91
29. McLean MH, Dieguez D, Miller LM, et al. Does the microbiota play a role in the pathogenesis of autoimmune diseases'. Gut. 2014; 64: 332-341
30. Wen L, Ley R, Volchkov P, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 2008; 455: 1109-1113
31. Larsen N, Vogensen F, Van Den Berg F, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010; 5: e9085
32. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60
33. Serino M, Luche E, Gres S, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut. 2012; 61: 543-553
34. Nielsen DS, Krych L, Buschard K, et al. Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes. FEBS Lett. 2014; 588: 4234-4243
35. Mayer E. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12: 453-466
36. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014; 146: 1500-1512
37. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013; 144: 1394-1401
38. Bruce-Keller A, Salbaum J, Luo M, et al. Obese-Type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry. 2015; 77: 607-615
39. Buie T, Fuchs G, Furuta G, et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010; 125(suppl 1): S19-S29
40. MacFabe D, Cain N, Boon F, et al. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition and neuro inflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res. 2011; 217: 47-54
41. Schulz MD, Atay Ç, Heringer J, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014; 514: 508-512
42. Castellarin M, Warren R, Freeman J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22: 299-306
43. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011; 6: e16393
44. Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis. MBio. 2013; 4
45. Pagnini C, Corleto VD, Mangoni ML, et al. Alteration of local microflora and a-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol. 2011; 45: 602-610
46. Elinav E, Nowarski R, Thaiss C, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013; 13: 759-771
47. Strober W, Fuss I, Blumberg R. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20: 495-549
48. Albenberg L, Wu G. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. 2014; 146: 1564-1572
49. De Filippo C, Cavalieri D, Paola MD, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010; 107: 14691-14696
50. Lee D, Albenberg L, Compher C, et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015; 148: 1087-1106
51. Jin D, Wu S, Zhang Y, et al. Lack of vitamin d receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther. 2015; 37: 996-1009
52. Assa A, Vong L, Pinnell L, et al. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury. Inflamm Bowel Dis. 2015; 21: 297-306
53. Assa A, Vong L, Pinnell L, et al. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014; 210: 1296-1305
54. Ooi J, Li Y, Rogers C, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr. 2013; 143: 1679-1686
55. Vitaglione P, Mennella I, Ferracane R, et al. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr. 2015; 101: 251-261
56. Ben Q, Sun Y, Chai R, et al. Dietary fiber intake reduces risk for colorectal adenoma: a meta- Analysis. Gastroenterology. 2014; 146: 689-699
57. Russell W, Gratz S, Duncan S, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. 2011; 93: 1062-1072
58. Chen HM, Yu YN, Wang JL, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr. 2013; 97: 1044-1052
59. Ou J, Carbonero F, Zoetendal E, et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013; 98: 111-120
60. Jacobs E, Lanza E, Alberts D, et al. Fiber, sex, and colorectal adenoma: results of a pooled analysis. Am J Clin Nutr. 2006; 83: 343-349
61. McCashland T, Brand R, Lyden E, et al. Gender differences in colorectal polyps and tumors. AM J Gastroenterol. 2001; 96: 882-886
62. Nomura A, Wilkens L, Murphy S, et al. Association of vegetable, fruit, and grain intakes with colorectal cancer: the Multiethnic Cohort Study. Am J Clin Nutr. 2008; 88: 730-737
63. Queipo-Ortuño M, Boto-Ordóñez M, Murri M, et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. 2012; 95: 1323-1334
64. Biswas A, Petnicki-Ocwieja T, Kobayashi K. Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med. 2012; 90: 15-24
65. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427-434
66. Kabi A, Nickerson K, Homer C, et al. Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis. 2012; 18: 782-792
67. Hugot J, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603
68. Petnicki-Ocwieja T, Hrncir T, Liu Y, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A. 2009; 106: 15813-15818
69. Bringiotti R, Ierardi E, Lovero R, et al. Intestinal microbiota: the explosive mixture at the origin of inflammatory bowel disease'. World J Gastrointest Pathophysiol. 2014; 5: 550-559
70. Abreu M, Taylor K, Lin Y, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002; 123: 679-688
71. Shaw M, Kamada N, Warner N, et al. The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol. 2011; 32: 73-79
72. Li E, Hamm C, Gulati A, et al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One. 2012; 7: e26284
73. Knights D, Silverberg M, Weersma R, et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. 2014; 6: 107
74. Friswell M, Campbell B, Rhodes J. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut and Liver. 2010; 4: 295-306
75. Cadwell K, Liu J, Brown S, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456: 259-263
76. Lassen K, Kuballa P, Conway K, et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci U S A. 2014; 111: 7741-7746
77. Raju D, Hussey S, Jones N. Crohn disease ATG16L1 polymorphism increases susceptibility to infection with Helicobacter pylori in humans. Autophagy. 2012; 8: 1387-1388
78. Lapaquette P, Glasser A, Huett A, et al. Crohn's disease-Associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 2010; 12: 99-113
79. Moran C, Walters T, Guo C, et al. IL-10R polymorphisms are associated with very-early- onset ulcerative colitis. Inflamm Bowel Dis. 2013; 19: 115-123
80. Shouval D, Biswas A, Goettel J, et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and antiinflammatory macrophage function. Immunity. 2014; 40: 706-719
81. Gassas A, Courtney S, Armstrong C, et al. Unrelated donor hematopoietic stem cell transplantation for infantile enteropathy due to IL-10/IL-10 receptor defect. Pediatr Transplant. 2015; 19: E101-E103
82. Engelhardt K, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- And IL-10 receptor- deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013; 131: 825-830
83. Murugan D, Albert M, Langemeier J, et al. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol. 2014; 34: 331-339
84. Glocker E, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. New Engl J Med. 2009; 361: 2033-2045
85. Goossens D, Jonkers D, Russel M, et al. The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon. Aliment Pharmacol Ther. 2006; 23: 255-263
86. Van Baarlen P, Troost F, Van Hemert S, et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A. 2009; 106: 2371-2376
87. Plaza-Diaz J, Fernandez-Caballero J, Chueca N, et al. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients. 2015; 7: 3999-4015
88. Solis B, Samartin S, Gomez S, et al. Probiotics as a help in children suffering from malnutrition and diarrhoea. Eur J Clin Nutr. 2002; 56 (suppl 3): S57-S59
89. Shen T, Albenberg L, Bittinger K, et al. Engineering the gut microbiota to treat hyperammonemia. J Clin Invest. 2015; 125: 2841-2850
90. Veiga P, Gallini C, Beal C, et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A. 2010; 107: 18132-18137
91. Ballal S, Veiga P, Fenn K, et al. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-Attenuating superoxide dismutase to inflamed colons. Proc Natl Acad Sci U S A. 2015; 112: 7803-7808
92. Brandt L, Aroniadis O, Mellow M, et al. Long-Term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012; 107: 1079-1087
93. Gough E, Shaikh H, Manges A. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53: 994-1002
94. Youngster I, Russell G, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014; 312: 1772-1778
95. Aroniadis O, Brandt L. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013; 29: 79-84
96. Khoruts A, Dicksved J, Jansson J, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-Associated diarrhea. J Clin Gastroenterol. 2010; 44: 354-360
97. Ianiro G, Bibbo S, Scaldaferri F, et al. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Med (Baltimore). 2014; 93: e97
98. Angelberger S, Reinisch W, Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013; 108: 1620-1630
99. Kassam Z, Lee C, Yuan Y, et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-Analysis. Am J Gastroenterol. 2013; 108: 500-508
100. Phillips M. Gut reaction: environmental effects on the human microbiota. Environ Health Perspect. 2009; 117: A198-A205
101. Biasucci G, Benenati B, Morelli L, et al. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr. 2008; 138: 1796S-800S.
102. Low D, Nguyen D, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013; 7: 1341-1357
103. Lewis M, Inman C, Patel D, et al. Direct experimental evidence that early-life farm environment influences regulation of immune responses. Pediatr Allergy Immunol. 2012; 23: 265-269
104. Erny D, Hrabe De Angelis A, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015; 18: 965-977
105. Thaiss CA, Zeevi D, Levy M, et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014; 159: 514-529